Discovery
Targets, mechanisms, proof of concept
French research. Industrial impact.
Find the right academic ATMP expertise for your R&D project.
Search 65 partnership offers across target discovery, preclinical validation, bioproduction, clinical development and real-world evidence — then connect with the relevant expert team.
65Partnership offers
9Carnot institutes
40+Platforms & technologies
1Coordinated entry point
Start from your R&D objective
What is your objective today?
Validate a therapeutic target
Identify and validate therapeutic targets and mechanisms.
See related offers →
Find a preclinical model
Access relevant in vitro, in vivo or organoid models for validation.
See related offers →
Access platforms & core facilities
Use specialist technologies, expert platforms and core facilities.
See related offers →
Prepare bioproduction
Develop and scale processes up to GMP or pre-GMP.
See related offers →
Build clinical evidence
Design studies and generate clinical evidence.
See related offers →
Share your project need
Send us a short description and the alliance team will direct it to the relevant expertise.
Send your project need →Why connected expertise makes the difference
Complex projects need connected answers.
The Carnot MTI Network connects complementary expertise, unique platforms and clinical resources to accelerate your ATMP development.
- From early research to real-world impact
- Academic excellence with industrial focus
- Confidential, flexible partnerships
- One contact to mobilize the right expertise
R&D value chain
One network across the ATMP development path.
Preclinical
Models, organoids, safety signals
Process
CMC, pre-GMP, GMP readiness
Clinical
Trials, infrastructure, evidence generation
Real-world
Registries, follow-up, long-term monitoring
Institutes
A compact view of participating Carnot partners.
AP-HP16 offers
CALYM8 offers
CEA-Leti4 offers
Curie Cancer13 offers
I2C5 offers
Imagine2 offers
OPALE4 offers
Paris Brain Institute2 offers
Voir & Entendre11 offers
Not sure where your need fits?